Ignite Creation Date:
2025-12-24 @ 7:47 PM
Ignite Modification Date:
2026-01-07 @ 8:38 PM
Study NCT ID:
NCT02219503
Status:
COMPLETED
Last Update Posted:
2021-07-12
First Post:
2014-08-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis
Sponsor:
AbbVie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-09
Start Date Type:
None
Primary Completion Date:
2015-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-09
Completion Date Type:
ACTUAL
First Submit Date:
2014-08-15
First Submit QC Date:
None
Study First Post Date:
2014-08-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-05-23
Results First Submit QC Date:
None
Results First Post Date:
2016-06-29
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-07-08
Last Update Post Date:
2021-07-12
Last Update Post Date Type:
ACTUAL